CHIRON
BiotechCHIRON is a biotechnology company focused on Oncology.
CHIRON's Key Drugs
CHIRON's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
CHIRON's Recent FDA Approvals
New NDA/BLA approvals for CHIRON over the last two years — novel drugs only, excluding generics and label supplements.
CHIRON's Therapeutic Areas
CHIRON's approved drugs and pipeline span 1 therapeutic area, led by Oncology, across 1 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
CHIRON's Top Competitors
CHIRON's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Novartis, and Merck. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
CHIRON Pipeline Snapshot
Active clinical trials for CHIRON across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1992-05-05
- Latest
- 2023-09-29
- Applications
- 1